Saturday, July 11, 2026

Drug profile · INN

enalapril

enalapril (ACETEC) is a angiotensin-converting enzyme inhibitor. Associated with Alphapharm Pty Ltd.

TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — enalapril

Quick answer

enalapril (ACETEC) is a angiotensin-converting enzyme inhibitor. Associated with Alphapharm Pty Ltd.

Key facts

INN enalapril
Brand ACETEC
Mechanism Angiotensin-converting enzyme inhibitor

Mechanism of action

Angiotensin-converting enzyme inhibitor

Approval history

Authority Status Date
TGA approved
NMPA clinical trials

Pipeline programs

  1. CXXB750A12201 Phase 2 · Novartis India · Heart Failure
  2. LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy Phase 2 · George Institute for · Colon cancer
  3. NN9388-7700 Phase 2 · NovoThirteen · Chronic Kidney Disease, Type 2 diabetes
  4. enalapril Phase 2 · Ultragenyx UK · Pseudohypoaldosteronism
  5. enalapril Unknown · Ultragenyx UK · IGA Glomerulonephritis

Frequently asked questions

What is enalapril?

enalapril (ACETEC) is a angiotensin-converting enzyme inhibitor. Associated with Alphapharm Pty Ltd.

What is the brand name for enalapril?

ACETEC is a marketed brand name for enalapril. Check FDA Drugs@FDA for the current US label holder and prescribing information.